Skip to main content
Tech.euFundingExplorerBeta

Kuros Biosciences

Kuros Biosurgery develops biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine.

Zurich, SwitzerlandFounded 2000www.kuros.ch ↗
Healthtech
← All companies
Total raised
€17M
€16,987,771
Funding rounds
2
Investors
2
distinct backers
Active since
2019-09
latest 2022-09

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood24
base rate 38% for Growth/Late
  • ▼ Overdue vs cohort gap
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
  • ▲ 26y since founding

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2022-09-16Growth/Late€6.2MOptiverder B.V,The Netherlands and Pegasus Global Opportunity Fund View deal →
2019-10-01Other€11M—View deal →

Investors

2
Optiverder B.VThe Netherlands and Pegasus Global Opportunity Fund

Related news

Similar companies

same sector or country